Trademark: 88433779
Status Date
Monday, October 31, 2022
Filing Date
Thursday, May 16, 2019
Published for Opposition
Tuesday, August 6, 2019
Abandoned Date
Monday, October 31, 2022
5 pharmaceutical preparations for the treatment of autoimmune diseases, rheumatoid arthritis, plaque psoriasis, crohn's disease, ulcerative colitis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis
Oct 31, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 31, 2022
Abandonment - No Use Statement Filed
Feb 26, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 24, 2022
Sou Extension 4 Granted
Feb 24, 2022
Sou Extension 4 Filed
Feb 24, 2022
Teas Extension Received
Sep 15, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 13, 2021
Sou Extension 3 Granted
Sep 13, 2021
Sou Extension 3 Filed
Sep 13, 2021
Teas Extension Received
Mar 2, 2021
Notice Of Approval Of Extension Request E-Mailed
Feb 26, 2021
Sou Extension 2 Granted
Feb 26, 2021
Sou Extension 2 Filed
Feb 26, 2021
Teas Extension Received
Aug 26, 2020
Notice Of Approval Of Extension Request E-Mailed
Aug 24, 2020
Sou Extension 1 Granted
Aug 24, 2020
Sou Extension 1 Filed
Aug 24, 2020
Teas Extension Received
Mar 24, 2020
Noa E-Mailed - Sou Required From Applicant
Feb 13, 2020
Extension Of Time To Oppose Process - Terminated
Sep 5, 2019
Extension Of Time To Oppose Received
Aug 6, 2019
Official Gazette Publication Confirmation E-Mailed
Aug 6, 2019
Published For Opposition
Jul 17, 2019
Notification Of Notice Of Publication E-Mailed
Jun 22, 2019
Approved For Pub - Principal Register
Jun 22, 2019
Assigned To Examiner
Jun 3, 2019
New Application Office Supplied Data Entered In Tram
May 20, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
